Compare Invesco WilderHill Clean Energy ETF (PBW) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco WilderHill Clean Energy ETF vs Pfizer Inc — how do they compare? Invesco WilderHill Clean Energy ETF trades at $28.33 (market cap $335.90M), while Pfizer Inc trades at $28.27 (market cap $158.56B). The key difference: Pfizer Inc is far larger — about 472× Invesco WilderHill Clean Energy ETF's market cap, and Pfizer Inc pays a 6.18% dividend while Invesco WilderHill Clean Energy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invesco WilderHill Clean Energy ETF for 46 Days and Pfizer Inc for 158 Days on average.
| PBW | PFE | |
|---|---|---|
Market Cap | $335.90M | $158.56B |
Volume | 628,890 | 44,138,282 |
Sector | Sector/Thematic | Health |
52-Week High | $46.99 | $29.02 |
52-Week Low | $28.29 | $23.67 |
Typical Hold Time | 46 Days | 158 Days |
Enterprise Value | — | $210.06B |
Dividend Yield | — | 6.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PBW (Invesco WilderHill Clean Energy ETF) trades at $28.33, down 2.04% with a bearish technical signal. The ETF's unique selection criteria prioritize ecological factors over financial metrics, resulting in concentrated exposure to clean energy companies. Recent institutional selling by IFP Advisors (-96.3% position) reflects caution amid sector volatility. Technical indicators show mixed signals with neutral oscillators but bearish moving averages.
Clean energy ETFs face headwinds from oil price volatility and tech sector weakness, though long-term energy transition trends provide growth potential. Key risks include undiversified portfolio concentration, geopolitical energy market impacts, and Federal Reserve policy uncertainty. The ETF's performance remains tied to clean energy adoption rates and government policy support.
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
